Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials.

Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B.

Chest. 2014 Apr;145(4):779-786. doi: 10.1378/chest.13-1235. Review.

PMID:
24202435
2.

Cardioselective beta-blockers for reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2002;(1):CD002992. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD002992.

PMID:
11869646
3.

Cardioselective beta-blocker use in patients with reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2001;(2):CD002992. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002992.

PMID:
11406056
4.

Cardioselective beta-blockers for reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2002;(4):CD002992. Review.

PMID:
12519582
5.

Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

Salpeter SR, Ormiston TM, Salpeter EE.

Ann Intern Med. 2002 Nov 5;137(9):715-25.

PMID:
12416945
6.
7.

Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma.

Salpeter SR, Ormiston TM, Salpeter EE.

Ann Intern Med. 2004 May 18;140(10):802-13.

PMID:
15148067
8.

Beta₂-agonists for exercise-induced asthma.

Bonini M, Di Mambro C, Calderon MA, Compalati E, Schünemann H, Durham S, Canonica GW.

Cochrane Database Syst Rev. 2013 Oct 2;(10):CD003564. doi: 10.1002/14651858.CD003564.pub3. Review.

PMID:
24089311
9.

Cardioselective beta-blockers for chronic obstructive pulmonary disease.

Salpeter SS, Ormiston T, Salpeter E, Poole P, Cates C.

Cochrane Database Syst Rev. 2002;(2):CD003566. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD003566.

PMID:
12076486
10.

Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.

Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH.

J Allergy Clin Immunol. 2014 Jul;134(1):40-5. doi: 10.1016/j.jaci.2013.10.057. Epub 2013 Dec 31.

PMID:
24388008
11.

Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.

Salpeter SR, Ormiston TM, Salpeter EE, Poole PJ, Cates CJ.

Respir Med. 2003 Oct;97(10):1094-101.

PMID:
14561016
12.

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.

Wong GW, Laugerotte A, Wright JM.

Cochrane Database Syst Rev. 2015 Aug 26;(8):CD007449. doi: 10.1002/14651858.CD007449.pub2. Review.

PMID:
26306578
13.

Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.

Kirkland SW, Vandenberghe C, Voaklander B, Nikel T, Campbell S, Rowe BH.

Cochrane Database Syst Rev. 2017 Jan 11;1:CD001284. doi: 10.1002/14651858.CD001284.pub2. Review.

PMID:
28076656
15.

Cardioselective beta-blockers for chronic obstructive pulmonary disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003566. Review.

PMID:
16235327
16.

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.

Geake JB, Dabscheck EJ, Wood-Baker R, Cates CJ.

Cochrane Database Syst Rev. 2015 Jan 10;1:CD010139. doi: 10.1002/14651858.CD010139.pub2. Review.

PMID:
25575340
17.

Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma.

Cazzola M, Noschese P, D'Amato M, D'Amato G.

Chest. 2000 Nov;118(5):1322-6.

PMID:
11083681
18.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816
20.

Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.

Spooner CH, Spooner GR, Rowe BH.

Cochrane Database Syst Rev. 2003;(4):CD002307. Review.

PMID:
14583951

Supplemental Content

Support Center